These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4854808)

  • 1. The effects of scopolamine on performance on a geometric progressive ratio schedule.
    Stewart WJ; Blampied NM; Hughes RN
    Psychopharmacologia; 1974; 38(1):55-66. PubMed ID: 4854808
    [No Abstract]   [Full Text] [Related]  

  • 2. A behavioral and pharmacological analysis of reinforcement withdrawal.
    Heise GA; Laughlin N; Keller C
    Psychopharmacologia; 1970; 16(5):345-68. PubMed ID: 5437556
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of scopolamine, amphetamine and chlordiazepoxide on punishment.
    Miczek KA
    Psychopharmacologia; 1973 Feb; 28(4):373-89. PubMed ID: 4633045
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative behavioral effects of several anticholinergic agents in rats.
    Pradhan SN; Roth T
    Psychopharmacologia; 1968; 12(4):358-66. PubMed ID: 5652217
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-muscarinic drug effects in a swim-to-platform test: dose-response relations.
    Vanderwolf CH
    Behav Brain Res; 1991 Aug; 44(2):217-9. PubMed ID: 1751013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated acquisition as a behavioral base line for studying drug effects.
    Thompson DM
    J Pharmacol Exp Ther; 1973 Feb; 184(2):506-14. PubMed ID: 4688186
    [No Abstract]   [Full Text] [Related]  

  • 7. Separating the effects of response rate and reinforcement frequency in the rate-dependent effects of amphetamine and scopolamine on the schedule-controlled performance of rats and pigeons.
    MacPhail RC; Gollub LR
    J Pharmacol Exp Ther; 1975 Aug; 194(2):332-42. PubMed ID: 1151762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The modification of drug effects on behavior by external discriminative stimuli.
    Laties VG
    J Pharmacol Exp Ther; 1972 Oct; 183(1):1-13. PubMed ID: 5080032
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of scopolamine, atropine, and d-amphetamine on internal and external control of responding on non-reinforced trials.
    Heise GA; Lilie NL
    Psychopharmacologia; 1970 Aug; 18(1):38-49. PubMed ID: 5523375
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of physostigmine, atropine and scopolamine on behavior maintained by a multiple schedule of food presentation in the mouse.
    Wenger GR
    J Pharmacol Exp Ther; 1979 Apr; 209(1):137-43. PubMed ID: 430373
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhancement by chlordiazepoxide of the anticholinergic-induced locomotor stimulation in mice.
    Sansone M; Hano J
    Psychopharmacology (Berl); 1979 Aug; 64(2):181-4. PubMed ID: 115038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminergic mechanisms in corpus striatum and amphetamine-induced stereotyped behaviour.
    Fog RL; Randrup A; Pakkenberg H
    Psychopharmacologia; 1967; 11(2):179-93. PubMed ID: 4871477
    [No Abstract]   [Full Text] [Related]  

  • 13. Intrahippocampal application of cholinergic agents and blockers: effects on rats in differential reinforcement of low rates and Sidman avoidance paradigms.
    Ross JF; Grossman SP
    J Comp Physiol Psychol; 1974 Apr; 86(4):590-600. PubMed ID: 4823234
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative effects of amphetamine, scopolamine, chlordiazepoxide, and diphenylhydantoin on operant and extinction behavior with brain stimulation and food reward.
    Olds ME
    Neuropharmacology; 1970 Nov; 9(6):519-32. PubMed ID: 5497006
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of scopolamine, amphetamine and benzodiazepines on conditioned suppression.
    Miczek KA
    Pharmacol Biochem Behav; 1973; 1(4):401-11. PubMed ID: 4204776
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship of the behavioral effects of aprophen, atropine and scopolamine to antagonism of the behavioral effects of physostigmine.
    Genovese RF; Elsmore TF; Witkin JM
    Pharmacol Biochem Behav; 1990 Sep; 37(1):117-22. PubMed ID: 2263653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antagonism of the central and peripheral effects of tremorine by 2 parasympatholytics: atropine and scopolamine].
    Fontaine O; Richelle M
    Psychopharmacologia; 1967; 11(2):154-64. PubMed ID: 5588186
    [No Abstract]   [Full Text] [Related]  

  • 18. Interaction of anticholinergic agents with -methyl-p-tyrosine and (+)-amphetamine.
    Sayers AC
    Br J Pharmacol; 1972 May; 45(1):170P-171P. PubMed ID: 5064932
    [No Abstract]   [Full Text] [Related]  

  • 19. Permanent facilitation of avoidance behavior by d-amphetamine and scopolamine.
    Barrett RJ; Leith NJ; Ray OS
    Psychopharmacologia; 1972; 25(4):321-31. PubMed ID: 5051145
    [No Abstract]   [Full Text] [Related]  

  • 20. Antagonism of oxotremorine-induced behavioral suppression by antimuscarinic drugs.
    Leander JD
    Psychopharmacology (Berl); 1981; 75(1):5-8. PubMed ID: 6795660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.